Application and Research of Left Bundle Branch-Optimized Cardiac Resynchronization Therapy in Ischemic Cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• Ischemic cardiomyopathy is a leading cause of heart failure with reduced ejection fraction.
• Cardiac resynchronization therapy (CRT) is a treatment option for eligible heart failure patients.
• Optimizing CRT delivery, such as with left bundle branch-optimized CRT (LOT-CRT), may improve outcomes.

Purpose of the Study:

• To evaluate the effectiveness of LOT-CRT compared to standard biventricular pacing (BVP) in patients with heart failure and reduced ejection fraction due to ischemic cardiomyopathy.
• To assess key pacing parameters, electrocardiographic changes, and cardiac function indicators between LOT-CRT and BVP groups.

Main Methods:

• A randomized study involving 78 patients with ischemic cardiomyopathy.
• Patients were assigned to either LOT-CRT (n=39) or BVP (n=35).
• Comparison of pacing thresholds, impedance, QRS duration, and cardiac ultrasound parameters at baseline, immediately post-surgery, and at six-month follow-up.

Main Results:

• LOT-CRT group showed significantly shorter QRS duration post-procedure and during follow-up compared to BVP (p < 0.001).
• While both groups showed modest improvements, the LOT-CRT group demonstrated significant improvements in NYHA class, LVEF, and LVEDD at six months (p < 0.001).
• The BVP group exhibited higher pacing thresholds and impedance, along with longer X-ray exposure times.

Conclusions:

• LOT-CRT is a viable alternative for heart failure patients with ischemic cardiomyopathy and left bundle branch block, especially when BVP is not effective.
• LOT-CRT demonstrates superior QRS narrowing and functional improvements compared to BVP in this patient cohort.
• Further research may explore LOT-CRT's long-term efficacy and broader applicability.